EMERYVILLE, Calif.--(BUSINESS WIRE)--BioTime, Inc. (OTCBB:BTIM) announced its plan to build a relational database for its Embryome Sciences subsidiary that will display information useful in identifying the hundreds of cell types that can be made from human and mouse embryonic stem cells. BioTime believes that this database will be the first of its kind in the stem cell field.
